Results 151 to 160 of about 18,252,794 (250)

Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

Life (Basel), 2021
Zhang Y, La B, Liang B, Gu Y.
europepmc   +1 more source

Editorial: Community series in reducing adverse effects of cancer immunotherapy, volume III

Frontiers in Immunology
Leonardo Vinícius Barbosa, Leonardo Vinícius Barbosa, Lara Luisa Valerio de Mello Braga, Lara Luisa Valerio de Mello Braga, Lucas Antonio Duarte Nicolau, Claire J. Han, Claire J. Han, Daniele Maria-Ferreira, Daniele Maria-Ferreira, Cleber Machado de Souza, Cleber Machado de Souza   +10 more
doaj   +1 more source

Ofatumumab Therapy and Long‐Term Seizure Outcomes of Patients With Relapsing Anti‐NMDA Receptor Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective There is a lack of studies on seizure outcomes associated with ofatumumab therapy in patients for relapsing anti‐N‐methyl‐D‐aspartate (NMDA) receptor encephalitis. We aimed to evaluate long‐term seizure outcomes of ofatumumab therapy for relapsing anti‐NMDA receptor encephalitis.
Jian Wang, Mengjiao Li, Ping Kong
wiley   +1 more source

Impact of EGFR variant allele frequency on treatment-related adverse events in patients with metastatic NSCLC treated with osimertinib. [PDF]

Front Mol Biosci
Shalata W, Krayim B, Miari A, Agbarya A, Lazarev I, Peled N, Dudnik Y, Cohen AY, Meirovitz A, Maimon Rabinovich N, Yakobson A, Abu Akar F, Brenner R.   +12 more
europepmc   +1 more source

Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis. [PDF]

Front Med (Lausanne), 2021
Du J, Han X, Lin S, Qiu C, Zhu L, Huang Z, Hou J.   +6 more
europepmc   +1 more source

Developing and Evaluating a Laboratory‐Based Frailty Index for the Prediction of Long‐Term Health Outcomes in Systemic Lupus Erythematosus

Arthritis Care &Research, EarlyView.
Objective We aimed to construct and evaluate the first laboratory‐based frailty index (FI‐Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. Methods We used data from a single‐center prospective cohort of adult patients with SLE whose baseline visit ...
Grace Burns, Samuel D. Searle, Alexandra Legge   +2 more
wiley   +1 more source

Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy. [PDF]

BMC Cancer
Xu XQ, Li WM, Shi LC, Wang H, Li S, Huang C, You H, Jia JD, He YW, Kong YY.   +9 more
europepmc   +1 more source

Sex-Specific Cut-Off Values for Low Skeletal Muscle Mass to Identify Patients at Risk for Treatment-Related Adverse Events in Head and Neck Cancer. [PDF]

J Clin Med, 2022
Zwart AT, Pörtzgen W, van Rijn-Dekker I, Sidorenkov GA, Dierckx RAJO, Steenbakkers RJHM, Wegner I, van der Hoorn A, de Bock GH, Halmos GB.   +9 more
europepmc   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli, Cecilia Nalli, Francesca Crisafulli, Carlo Garaffoni, Marcello Govoni, Giulia Voltarel, Alba C. Pozzi, Beatrice Maranini, Ettore Silvagni, Alessandra Bortoluzzi, Angela Tincani   +10 more
wiley   +1 more source

Reporting of adverse events related to dietary supplements to a public health center by medical staff: a survey of clinics and pharmacies

, 2016
Kazuki Ide,1 Hiroshi Yamada,1 Yohei Kawasaki,1 Marika Noguchi,1 Mamoru Kitagawa,1 Tsuyoshi Chiba,2 Yoshiyuki Kagawa,3 Keizo Umegaki2 1Department of Drug Evaluation & Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka ...
Kitagawa M, Kawasaki Y, Kagawa Y, Ide K, Chiba T, Yamada H, Umegaki K, Noguchi M   +7 more
core